A challenge model for Shigella dysenteriae 1 in cynomolgus monkeys (Macaca fascicularis)

Comparative Medicine

Volumn 60, Issue 1, 2010, Pages 54-61

  Shipley, Steven T ^a   Panda, Aruna ^a   Khan, Abdul Q ^b   Kriel, Edwin H ^a   Maciel Jr , Milton ^b   Livio, Sofie ^b   Nataro, James P ^b   Levine, Myron M ^b   Sztein, Marcelo B ^b   DeTolla, Louis J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b University of Maryland School of Medicine Center for Vaccine Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CEFTRIAXONE; ENROFLOXACIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; COLONY FORMING UNIT; DIARRHEA; EXPERIMENTAL INFECTION; FECES; FECES ANALYSIS; FEMALE; IMMUNE RESPONSE; MACACA; MALE; NONHUMAN; REPRODUCIBILITY; SHIGELLA DYSENTERIAE; SHIGELLOSIS; WILD TYPE;

ANIMALS; AUTOANTIBODIES; FECES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MACACA FASCICULARIS; MODELS, ANIMAL; SHIGELLA DYSENTERIAE;

EID: 77749270726     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Animal Welfare Act as Amended. 2007.7 USC §2131-2156.
2. Centers for Disease Control and Prevention and National Institutes of Health. [Internet]. 2007. Biosafety in microbiological and biomedical laboratories (BMBL), 5th ed. [Cited Jan 2007]. Available at http://www.cdc.gov/ OD/ohs/biosfty/bmbl5/bmbl5toc.htm.
3. Dinari G, Hale TL, Austin SW, Formal SB. 1987. Local and systemic antibody responses to Shigella infection in rhesus monkeys. J Infect Dis 155:1065-1069.
4. Fernandez MI, Thuizat A, Pedron T, Neutra M, Phalipon A, Sansonetti PJ. 2003. A newborn mouse model for the study of intestinal pathogenesis of shigellosis. Cell Microbiol 5:481-491.
5. Formal SB, Hale TL, Kapfer C, Cogan JP, Snoy PJ, Chung R, Wingfield ME, Elisberg BL, Baron LS. 1984. Oral vaccination of monkeys with an invasive Escherichia coli K12 hybrid expressing Shigella flexneri 2a somatic antigen. Infect Immun 46:465-469.
6. Formal SB, Kent TH, May HC, Palmer A, Falkow S, LaBrec EH. 1966. Protection of monkeys against experimental shigellosis with a living attenuated oral polyvalent dysentery vaccine. J Bacteriol 92:17-22.
7. Formal SB, LaBrec EH, Palmer A, Falkow S. 1965. Protection of monkeys against experimental shigellosis with attenuated vaccines. J Bacteriol 90:63-68.
8. Formal SB, Oaks EV, Olsen RE, Wingfield-Eggleston M, Snoy PJ, Cogan JP. 1991. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei. J Infect Dis 164:533-537.
9. Gemski P Jr, Takeuchi A, Washington O, Formal SB. 1972. Shigellosis due to Shigella dysenteriae. 1. Relative importance of mucosal invasion versus toxin production in pathogenesis. J Infect Dis 126:523-530.
10. Institute of Laboratory Animal Resources. 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academies Press.
11. Karnell A, Reinholt FP, Katakura S, Lindberg AA. 1991. Shigella flexneri infection: a histopathologic study of colonic biopsies in monkeys infected with virulent and attenuated bacterial strains. APMIS 99:787-796.
12. Katakura S, Reinholt FP, Karnell A, Huan PT, Trach DD, Lindberg AA. 1990. The pathology of Shigella flexneri infection in rhesus monkeys: an endoscopic and histopathological study of colonic lesions. APMIS 98:313-319.
13. Kweon MN. 2008. Shigellosis: the current status of vaccine development. Curr Opin Infect Dis 21:313-318.
14. Levine MM, DuPont HL, Formal SB, Hornick RB, Takeuchi A, Gangarosa EJ, Snyder MJ, Libonati JP. 1973. Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery. J Infect Dis 127:261-270.
15. Levine MM, Kotloff KL, Barry EM, Pasetti MF, Sztein MB. 2007. Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nat Rev Microbiol 5:540-553.
16. Mallett CP, Hale TL, Kaminski RW, Larsen T, Orr N, Cohen D, Lowell GH. 1995. Intransal or intragastric immunization with proteosome- Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection. Infect Immun 63:2382-2386.
17. McIver J, Grady GF, Formal SB. 1977. Immunization with Shigella dysenteriae type 1: evaluation of antitoxic immunity in prevention of experimental disease in rhesus monkeys (Macaca mulatta). J Infect Dis 136:416-121.
18. O'Brien AD, Holmes RK. 1987. Shiga and Shiga-like toxins. Microbiol Rev 51:206-220.
19. Oaks EV, Hale TL, Formal SB. 1986. Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp. Infect Immun 53:57-63.
20. Ogawa M, Sasakawa C. 2006. Intracellular survival of Shigella. Cell Microbiol 8:177-184.
21. Rabbani GH, Albert MJ, Rahman H, Islam M, Mahalanabis D, Kabir I, Alam K, Ansaruzzaman M. 1995. Development of an improved animal model of shigellosis in the adult rabbit by colonic infection with Shigella flexneri 2a. Infect Immun 63:4350-4357.
22. Rout WR, Formal SB, Giannella RA, Dammin GJ. 1975. Pathophysiology of Shigella diarrhea in the rhesus monkey: intestinal transport, morphological, and bacteriological studies. Gastroenterology 68:270-278.
23. Russell RG, DeTolla LJ. 1993. Shigellosis, p 46-53. In: Jones TH, Mohr U, Hunt RD, editors. Nonhuman primates II. Berlin (Germany): Springer-Verlag.
24. Sereny B. 1955. Experimental Shigella keratoconjunctivitis; a preliminary report. Acta Microbiol Acad Sci Hung 2:293-296.
25. Shim DH, Suzuki T, Chang SY, Park SM, Sansonetti PJ, Sasakawa C, Kweon MN. 2007. New animal model of shigellosis in the guinea pig: its usefulness for protective efficacy studies. J Immunol 178:2476-2482.
26. Takeuchi A. 1982. Early colonic lesions in experimental Shigella infection in rhesus monkeys: revisited. Vet Pathol Suppl 7:1-8.
27. Takeuchi A, Jervis HR, Formal SB. 1975. Animal model of human disease. Bacillary dysentery, shigellosis, Shigella dysentery. Animal model: monkey shigellosis or dysentery. Am J Pathol 81:251-254.
28. Venkatesan MM, Hartman AB, Newland JW, Ivanova VS, Hale TL, McDonough M, Butterton J. 2002. Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine. Infect Immun 70:2950-2958.
29. Wynne ES, Henrikson DM, Daye GT Jr. 1970. Persistence of an Escherichia coli-Shigella flexneri hybrid in the intestinal tract of Macaca mulatta. Appl Microbiol 19:731-733.
30. Zhang Z, Jin L, Champion G, Seydel KB, Stanley SL Jr. 2001. Shigella infection in a SCID mouse-human intestinal xenograft model: role for neutrophils in containing bacterial dissemination in human intestine. Infect Immun 69:3240-3247.